We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,912 results
  1. Self-delivery photothermal-boosted-nanobike multi-overcoming immune escape by photothermal/chemical/immune synergistic therapy against HCC

    Immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy have shown encouraging clinical benefits for the treatment of unresectable...

    Huizhen Yang, Weiwei Mu, ... Na Zhang in Journal of Nanobiotechnology
    Article Open access 29 March 2024
  2. FGL1 Promotes Tumor Immune Escape in Stomach Adenocarcinoma via the Notch Signaling Pathway

    Immune escape is the major reason for immunotherapy failure in stomach adenocarcinoma (STAD). We tried to reveal the underlying mechanism of FGL1...

    Yani Zhou, Dan Liu, Huirong Li in Molecular Biotechnology
    Article 30 October 2023
  3. Circular RNA AGAP1 Stimulates Immune Escape and Distant Metastasis in Renal Cell Carcinoma

    Clear cell renal cell carcinoma (ccRCC) is the most representative subtype of renal cancer, with a highly aggressive phenotype and extremely poor...

    ChangGuo Du, QunFeng Yan, ... MingBao Ye in Molecular Biotechnology
    Article 18 May 2023
  4. Th9 Cytokines Inhibit Proliferation, Promote Apoptosis, and Immune Escape in Thyroid Carcinoma Cells

    To investigate the regulatory effects of T helper 9 (Th9) cytokines on the proliferation, apoptosis and immune escape of thyroid cancer cells. The...

    **nyu Ying, **nyi Ma, ... Bo Zhou in Applied Biochemistry and Biotechnology
    Article 15 January 2024
  5. Circ_0007422 Knockdown Inhibits Tumor Property and Immune Escape of Colorectal Cancer by Decreasing PDL1 Expression in a miR-1256-Dependent Manner

    Circular RNAs (circRNAs) are a group of important molecules involved in the progression of various cancers, including colorectal cancer (CRC). Here,...

    Dian Yin, Li Yang, ... Ying Chen in Molecular Biotechnology
    Article 22 January 2024
  6. E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1 Expression

    Head and neck squamous cell carcinoma (HNSCC) is a lethal malignancy. Given the essential roles of E3 ligases in cancer immunotherapies, this paper...

    Cuihong Jiang, Lili He, ... Feng Liu in Molecular Biotechnology
    Article 07 November 2022
  7. N6-Methyladenosine (m6A) Reader IGF2BP1 Accelerates Gastric Cancer Development and Immune Escape by Targeting PD-L1

    N 6 -methyladenosine (m 6 A) functions as an important regulator in various human cancers, including gastric cancer. The immunotherapy targeting...

    Bingxi Tang, Lei Bi, ... **nli Li in Molecular Biotechnology
    Article 10 October 2023
  8. Microbial hydrogen “manufactory” for enhanced gas therapy and self-activated immunotherapy via reduced immune escape

    Background

    As an antioxidant, hydrogen (H 2 ) can selectively react with the highly toxic hydroxyl radical (·OH) in tumor cells to break the balance of...

    Hongyu Yan, Miao Fan, ... Zhenhua Li in Journal of Nanobiotechnology
    Article Open access 15 June 2022
  9. Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viral mutants

    Objective

    The COVID-19 epidemic is raging around the world, with the emergence of viral mutant strains such as Delta and Omicron, posing severe...

    Yan Cheng, Dan Zheng, ... Ting Luo in Journal of Molecular Modeling
    Article 24 March 2023
  10. Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy

    Immunotherapy has emerged as a transformative approach in the treatment of various cancers, offering new hope for patients previously faced with...

    Sidhartha Singh, Navneet Singh, ... Sandeep Kumar in 3 Biotech
    Article 21 November 2023
  11. Regenerative Capacity and the Develo** Immune System

    Many components of the vertebrate immune system have evolved with dual, interrelated functions of both protecting injured tissues from infection and...
    Anthony L. Mescher, Anton W. Neff in Regenerative Medicine I
    Chapter
  12. Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy

    Immune checkpoint (ICP) molecules expressed on tumor cells can suppress immune responses against tumors. ICP therapy promotes anti-tumor immune...

    Seyed Hossein Kiaie, Hossein Salehi-Shadkami, ... Mohammad Sheibani in Journal of Nanobiotechnology
    Article Open access 21 September 2023
  13. Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1)

    Herein, we conducted simulations of trimeric Spike from several SARS-CoV-2 variants of concern (Delta and Omicron sub-variants BA.2, BA.5, and BQ.1)...

    Anacleto Silva de Souza, Robson Francisco de Souza, Cristiane Rodrigues Guzzo in Journal of Computer-Aided Molecular Design
    Article 04 October 2023
  14. A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune

    Background

    Combination therapy involving immune checkpoint blockade (ICB) and other drugs is a potential strategy for converting immune-cold tumors...

    Zhenzhen Jiang, Guangqing Cai, ... Yanwei Luo in Journal of Nanobiotechnology
    Article Open access 29 May 2024
  15. Clinical Significance and Immune Infiltration Analyses of a Novel Nerve-Related lncRNA Signature in Gastric Cancer

    Gastric cancer (GC) is a progressive disease with high morbidity and mortality. Accumulating evidence indicated that nervous system-cancer crosstalk...

    Lupeng Qiu, Yaru Liu, ... Shunchang Jiao in Molecular Biotechnology
    Article 25 December 2023
  16. Activation of MAL2 by RAD21 inhibits the expression of MHC-I in immune evasion of endometrial cancer

    CD8 + T cells are the primary mediators of anticancer immunity, and modulation of the CD8 + T cell response has been a central focus of immunotherapy...

    Yuni **, **aoning Lu, ... Huiming Guo in Cytotechnology
    Article 24 April 2024
  17. Structural dissimilarity from self drives neoepitope escape from immune tolerance

    T-cell recognition of peptides incorporating nonsynonymous mutations, or neoepitopes, is a cornerstone of tumor immunity and forms the basis of new...

    Jason R. Devlin, Jesus A. Alonso, ... Brian M. Baker in Nature Chemical Biology
    Article 17 August 2020
  18. Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction

    Radiotherapy-induced immune activation holds great promise for optimizing cancer treatment efficacy. Here, we describe a clinically used...

    Honglei Hu, Shuting Zheng, ... Chenggong Yan in Journal of Nanobiotechnology
    Article Open access 09 May 2024
  19. Double-layered N-S1 protein nanoparticle immunization elicits robust cellular immune and broad antibody responses against SARS-CoV-2

    Background

    The COVID-19 pandemic is a persistent global threat to public health. As for the emerging variants of SARS-CoV-2, it is necessary to...

    Ruiqi Li, Zejie Chang, ... Gai** Zhang in Journal of Nanobiotechnology
    Article Open access 30 January 2024
  20. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response

    Tumor vaccines, a crucial immunotherapy, have gained growing interest because of their unique capability to initiate precise anti-tumor immune...

    Yongchao Zha, Li Fu, ... Linghong Huang in Journal of Nanobiotechnology
    Article Open access 08 May 2024
Did you find what you were looking for? Share feedback.